SNGX News and Press, Soligenix Inc. From 01/25/21

New York, New York--(Newsfile Corp. - January 25, 2021) - PCG Digital: Advancing health care innovation is a cornerstone of thorough public health policy. Researching and developing new treatments for unmet medical needs has become increasingly important as the world continues to battle throug...

Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma Conference Call Tuesday, January 26, 2021 at 2:30 PM EST PR Newswire PRINCETON, N.J. , Jan. 19, 2021 /PRNewswire/ -- Soligenix, Inc...

Soligenix (SNGX) perks 8% premarket after signing an exclusive Supply, Distribution and Services Agreement with Daavlin.Pursuant to the Agreement, Daavlin will exclusively manufacture the proprietary light device for use with SGX301 (synthetic hypericin) for the treatment ...

Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma -- Providing an end-to-end business solution for our customers -- Ensuring seamless integration of drug and l...

National Institute of Allergy and Infectious Diseases awarded Soligenix (SNGX) a Direct to Phase II Small Business Innovation Research ((SBIR)) grant of ~$1.5M for supporting, manufacturing, formulation and characterization of COVID-19 and EVD vaccine candidates in conjunction with ...

Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development Supports CoVaccine HT™ platform development PR Newswire PRINCETON, N.J. , Dec. 28, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: S...

Gainers: Ocugen (OCGN) +114%.Big Rock Partners Acquisition (BRPA) +110%.Aurora Mobile (JG) +50%.Aqua Metals (AQMS) +45%.NantHealth (NH) +39%.Sportsman's Warehouse Holdings (SPWH) +37%.Aemetis (AMTX) +30%.Foresight Autonomous Holdings (FRSX) +29%.QuantumScape (QS) +28%.Cyclacel Pharmaceut...

Gainers: Ocugen (OCGN) +90%, NantHealth (NH) +35%, Organovo (ONVO) +25%, Genprex (GNPX) +23%, Spero Therapeutics (SPRO) +14%.Losers: Soligenix (SNGX) -54%, SOS (SOS) -39%, Venus Concept (VERO) -23%, BioCryst Pharmaceuticals...

Soligenix (SNGX) plunges 44% premarket in reaction to the announcement of preliminary top-line results for its Phase 3 DOM-INNATE (Dusquetide treatment in Oral Mucositis – by modulating INNATE Immunity) trial evaluating SGX942 (dusquetide) in the treatment of severe oral muco...

Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients Company to Host Investor Conference Call Today at 8:30AM EST PR Newswire PRINCETON, N.J. , Dec. 22, 2020 /PRNews...